Wall Street is positive on Evelo Biosciences Inc (EVLO). On average, analysts give Evelo Biosciences Inc a Hold rating. The average price target is $10, which means analysts expect the stock to increase by 1718.18% over the next twelve months. That average ranking earns Evelo Biosciences Inc an Analyst Rating of 5, which is better than 5% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating EVLO a Hold today. Find out what this means to you and get the rest of the rankings on EVLO!